...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trodelvy - development history and valuations along the way

Doesn't Zenith already has a licensing agreement with NewSoara for a upfront payment of 3.5M?

https://www.zenithepigenetics.com/newsroom/news-releases.html?article=52

 

Share
New Message
Please login to post a reply